P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis ; volume:22 ; number:3 ; day:2 ; month:3 ; year:2023 ; pages:391-399 ; date:3.2023
Nature materials ; 22, Heft 3 (2.3.2023), 391-399, 3.2023
- Urheber
-
Tylawsky, Daniel E.
Kiguchi, Hiroto
Vaynshteyn, Jake
Gerwin, Jeffrey
Shah, Janki
Islam, Taseen
Boyer, Jacob A.
Boué, Daniel R.
Snuderl, Matija
Greenblatt, Matthew B.
Shamay, Yosi
Raju, G. Praveen
Heller, Daniel A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41563-023-01481-9
- URN
-
urn:nbn:de:101:1-2023111610414269878179
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tylawsky, Daniel E.
- Kiguchi, Hiroto
- Vaynshteyn, Jake
- Gerwin, Jeffrey
- Shah, Janki
- Islam, Taseen
- Boyer, Jacob A.
- Boué, Daniel R.
- Snuderl, Matija
- Greenblatt, Matthew B.
- Shamay, Yosi
- Raju, G. Praveen
- Heller, Daniel A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The final frontier – crossing the blood‐brain barrier
Advances in blood–brain barrier-crossing nanomedicine for anti-glioma
Targeted delivery of tyrosine kinase inhibitors across the blood-brain barrier with functionalized liposomal nanocarriers
Biocompatible nanocarriers
Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
Nachweis von induzierbaren Zelladhäsionsmolekülen (PECAM, VCAM, E-Selectin und P-Selectin) im Schweinemodell
Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1
Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers
Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers
Multifunctional pharmaceutical nanocarriers
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging
Klonierung des muskelspezifischen Caveolin-3 und transkriptionelle Regulation des Caveolin-3-Promoters
The final frontier – crossing the blood‐brain barrier
Advances in blood–brain barrier-crossing nanomedicine for anti-glioma
Targeted delivery of tyrosine kinase inhibitors across the blood-brain barrier with functionalized liposomal nanocarriers
Biocompatible nanocarriers
Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
Nachweis von induzierbaren Zelladhäsionsmolekülen (PECAM, VCAM, E-Selectin und P-Selectin) im Schweinemodell
Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1
Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers
Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers
Multifunctional pharmaceutical nanocarriers
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging
Klonierung des muskelspezifischen Caveolin-3 und transkriptionelle Regulation des Caveolin-3-Promoters
The final frontier – crossing the blood‐brain barrier
Advances in blood–brain barrier-crossing nanomedicine for anti-glioma
Targeted delivery of tyrosine kinase inhibitors across the blood-brain barrier with functionalized liposomal nanocarriers
Biocompatible nanocarriers
Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
Nachweis von induzierbaren Zelladhäsionsmolekülen (PECAM, VCAM, E-Selectin und P-Selectin) im Schweinemodell
Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1
Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers
Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers
Multifunctional pharmaceutical nanocarriers
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging